Shivahi Exim is a global pharmaceutical and nutraceutical company committed to delivering high-quality medicines to patients worldwide. With GMP-certified manufacturing, in-house regulatory expertise, and a relentless drive for innovation, we proudly serve partners across 30+ countries.
Shivahi Exim is a Pharmaceutical and Nutraceutical company based in India with a focus on delivering high-quality medicines to patients worldwide. We are a group of companies with state-of-the-art manufacturing facilities complying with stringent regulatory standards including US-FDA, EU-GMP, Health Canada, PIC/S, and WHO-cGMP certifications. We specialize in manufacturing and distribution of high-quality pharmaceuticals, nutraceuticals, and veterinary products globally.
At the heart of everything we do is a relentless drive to innovate. We are committed to pharmaceutical research and development, with identifying and advancing next-generation therapeutic solutions. Our in-house Regulatory Affairs team is made up of professionals with strong expertise in global regulatory frameworks and compliance requirements.
At Shivahi, quality meets affordability. We are dedicated to supplying highest quality medicines at competitive prices with regulatory support, ensuring every customer receives outstanding value.
We are a one-stop destination for pharmaceutical formulation development, clinical trials, bioequivalence studies, and contract manufacturing.
We manufacture a comprehensive range of pharmaceutical formulations including tablets, capsules, injectables, and more, compliant with global GMP standards.
We produce high-quality nutritional supplements and health products certified by Health Canada and US FDA, serving diverse wellness segments globally.
Our veterinary division develops and manufactures pharmaceutical and nutraceutical products for companion animals, livestock, poultry, and aquaculture worldwide.
We bring efficiency, expertise, and commitment to every partnership. By combining deep market knowledge, a strong established customer base, and proven ground-level operations, we help our partners reduce risks, lower fixed costs, and expand their product reach globally.
Looking for a cost-effective market approach with consistent access to quality pharmaceutical products, without stretching your sales resources?
One of our core strengths lies in manufacturing niche and specialty molecules including products in underserved therapeutic areas that remain largely untapped commercially. We are dedicated to making these high-need medicines accessible without compromising on quality, consistency, or regulatory compliance.
We bring efficiency, expertise, and commitment to every partnership. By combining deep market knowledge, a strong established customer base, and proven ground-level operations, we help our partners reduce risks, lower fixed costs, and expand their product reach globally.
Our facilities comply with US FDA, EU GMP, Health Canada, PIC/S, and WHO-cGMP standards — ensuring world-class product quality at every stage.
Our in-house regulatory team prepares CTD, eCTD, and ACTD dossiers supporting seamless product registration across 30+ countries.
Ready dossiers filed across 30+ countries, enabling seamless market entry for partners globally through COPP and FSC documentation.
Connect with our team to explore partnership opportunities — Contact Us
Our footprint spans EAEU, CIS, Africa, MENA, Asia Pacific, LATAM, and the Americas — supported by deep regional expertise, regulatory know-how, and trusted business relationships.
We manufacture a comprehensive range of pharmaceuticals including tablets (IR/XR/ODT/Chewable), capsules, injectables, infusions, pre-filled syringes, inhalers, eye drops, oral powders, syrups, and topical preparations. We also produce nutraceuticals and veterinary pharmaceutical products.
Our manufacturing facilities are accredited by US FDA, Health Canada, EU GMP, PIC/S, and WHO-cGMP. We are also actively pursuing additional certifications from MHRA (UK) and TGA (Australia) to further expand our global compliance footprint.
Yes. Our in-house regulatory affairs team prepares high-quality dossier submissions in CTD, eCTD, ACTD, and ICH formats, including COPP and FSC documentation to support smooth and timely market registration across global territories.
Yes. We offer comprehensive CDMO and CMO services tailored to our clients' requirements, from formulation development and technology transfer to full-scale GMP-compliant commercial production. Contact us for CMO/CDMO enquiries.
